A detailed history of Brevan Howard Capital Management LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 97,340 shares of BSX stock, worth $9.81 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
97,340
Previous 32,851 196.31%
Holding current value
$9.81 Million
Previous $2.75 Million 215.92%
% of portfolio
0.06%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$83.62 - $91.5 $5.39 Million - $5.9 Million
64,489 Added 196.31%
97,340 $8.69 Million
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $1.41 Million - $1.62 Million
19,331 Added 142.98%
32,851 $2.75 Million
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $910,301 - $1.05 Million
13,520 New
13,520 $1.04 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $144B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.